The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer

Over the past 10 years, cancer immunotherapy has made significant progress in multiple cancer types and has been gradually been applied to clinical cancer care, in which the programmed cell death protein-1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is one of the most attractive targets. C...

Full description

Bibliographic Details
Main Authors: Xin-wei Qiao, Jian Jiang, Xin Pang, Mei-chang Huang, Ya-jie Tang, Xin-hua Liang, Ya-ling Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
PD-1
PD-L1
head and neck
prognostic
immunotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.01721/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.01721/full

Similar Items